文献
J-GLOBAL ID:201802234875638655
整理番号:18A0289187
再発性肺小細胞癌における,DLL3標的抗体 薬剤複合体Rovalpituzumab tesirine:初のヒト,初のクラス,非盲検,第1相試験【Powered by NICT】
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
著者 (27件):
Rudin Charles M
(Memorial Sloan Kettering Cancer Center, New York, NY, USA)
,
Pietanza M Catherine
(Memorial Sloan Kettering Cancer Center, New York, NY, USA)
,
Bauer Todd M
(Tennessee Oncology PLLC, Nashville, TN, USA)
,
Bauer Todd M
(Sarah Cannon Research Institute, Nashville, TN, USA)
,
Ready Neal
(Duke University Medical Center, Durham, NC, USA)
,
Morgensztern Daniel
(Washington University School of Medicine in St Louis, St Louis, MO, USA)
,
Glisson Bonnie S
(University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Byers Lauren A
(University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Johnson Melissa L
(Tennessee Oncology PLLC, Nashville, TN, USA)
,
Johnson Melissa L
(Sarah Cannon Research Institute, Nashville, TN, USA)
,
Burris Howard A
(Tennessee Oncology PLLC, Nashville, TN, USA)
,
Burris Howard A
(Sarah Cannon Research Institute, Nashville, TN, USA)
,
Robert Francisco
(University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL, USA)
,
Han Tae H
(Stemcentrx Inc, South San Francisco, CA, USA)
,
Bheddah Sheila
(Stemcentrx Inc, South San Francisco, CA, USA)
,
Theiss Noah
(Ventana Medical Systems Inc, Tucson, AZ, USA)
,
Watson Sky
(Ventana Medical Systems Inc, Tucson, AZ, USA)
,
Mathur Deepan
(Ventana Medical Systems Inc, Tucson, AZ, USA)
,
Vennapusa Bharathi
(Ventana Medical Systems Inc, Tucson, AZ, USA)
,
Zayed Hany
(Stemcentrx Inc, South San Francisco, CA, USA)
,
Lally Satwant
(Stemcentrx Inc, South San Francisco, CA, USA)
,
Strickland Donald K
(Sarah Cannon Research Institute, Nashville, TN, USA)
,
Govindan Ramaswamy
(Washington University School of Medicine in St Louis, St Louis, MO, USA)
,
Dylla Scott J
(Stemcentrx Inc, South San Francisco, CA, USA)
,
Peng Stanford L
(Stemcentrx Inc, South San Francisco, CA, USA)
,
Spigel David R
(Tennessee Oncology PLLC, Nashville, TN, USA)
,
Spigel David R
(Sarah Cannon Research Institute, Nashville, TN, USA)
資料名:
Lancet Oncology
(Lancet Oncology)
巻:
18
号:
1
ページ:
42-51
発行年:
2017年
JST資料番号:
W1266A
ISSN:
1470-2045
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)